GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citi Pharma Ltd (KAR:CPHL) » Definitions » Net Income (Continuing Operations)

Citi Pharma (KAR:CPHL) Net Income (Continuing Operations) : ₨0.00 Mil (TTM As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is Citi Pharma Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Citi Pharma's Net Income (Continuing Operations) for the six months ended in . 20 was ₨0.00 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in . 20 was ₨0.00 Mil.

Citi Pharma Net Income (Continuing Operations) Historical Data

The historical data trend for Citi Pharma's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Citi Pharma Net Income (Continuing Operations) Chart

Citi Pharma Annual Data
Trend
Net Income (Continuing Operations)

Citi Pharma Semi-Annual Data
Net Income (Continuing Operations)

Citi Pharma Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in . 20 was ₨0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Citi Pharma  (KAR:CPHL) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Citi Pharma Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Citi Pharma's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Citi Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Citi Pharma Ltd (KAR:CPHL) » Definitions » Net Income (Continuing Operations)
Comparable Companies
KAR:MACTER KAR:FEROZ KAR:SEARL KAR:AGP KAR:ABOT ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR
Traded in Other Exchanges
N/A
Address
588 Q Block, Johar Town, Lahore, PB, PAK
Website
http://www.citipharma.com.pk
Citi Pharma Ltd is engaged in the manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. Its departments include Active Pharma Ingredients (API) and Formulations. Some of its products include Askprol C Tab, Lenon Tab, Recoz Tab, Cingol Tab among others.

Citi Pharma Headlines

No Headlines